RxDoctor Payments Data

Armin Arshi, MD

Adult Reconstructive Orthopaedic Surgery · Los Alamitos, CANPI 1790148070

Payments from drug & device makers

What this record shows

This record is dominated by education: $6,250 of the $9,645 with a category attached, or 64.8%. Smith+Nephew accounts for 69.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $4,361 and has fallen 79.2% since, to $907 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in CA, where the typical reported total is $9,645.

$9,645in general payments, 2019–2025

Across 53 payments — averaging $181.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$7K
  • Stryker$2K
  • Johnson & Johnson$202
  • Davol Inc.$159
  • Vertex$81
  • Bioventus LLC$39
  • plus $83 from 3 others
$19,106in research payments, 2019–2025

Across 2 payments — averaging $9552.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$19K

What the payments were for

  • Travel & lodging$6737%
  • Food & beverage$2,72228%
  • Education$6,25065%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,645 in reported general payments places this provider in the 50th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$332,500
Medicare patients
440
Services billed
2,360

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium351$43,453
Ondansetron Hcl12$2,666
Meloxicam155$491
Celecoxib11$189
Tramadol Hcl44$94
Methylprednisolone15$72
Amoxicillin62$61
Oxycodone Hcl18$26
Famotidine11$24

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Los Alamitos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →